Oncology Practice

What Oncology Practice does

Onkologische Praxis Rehling is a privately owned, single-site hematology-oncology medical practice located in Rehling, Germany, north of Augsburg. Founded in 2003 by Dr. med. Stephan Hochdörfer, the practice provides comprehensive outpatient diagnosis, therapy, and follow-up care for solid tumors, hematologic malignancies, and coagulation disorders, and offers palliative medicine. Its service portfolio spans diagnostics (ultrasound, bone marrow and other punctures, endoscopy, ECG, cytology), and treatment modalities including chemotherapy, immunotherapy, targeted therapy, transfusions, pain management, and supportive care, all delivered in an attached day clinic (Tagesklinik). The core technology is standard medical practice; there is no proprietary software, AI/ML system, or technology platform disclosed.

The practice operates with approximately 15 staff including three physicians — Dr. Hochdörfer (internist, hematologist, oncologist), Dr. Monika Pintsch (internist, hematologist, oncologist, palliative medicine specialist, joined October 2023), and Sabine Gliemann (internist, palliative medicine specialist) — supported by medical assistants and nursing staff. Revenue is generated through reimbursement from German statutory health insurance (GKV) under the EBM catalog and private health insurance (PKV) under the GOÄ fee schedule. Pricing is regulated rather than market-determined, and per-service reimbursement rates are not publicly disclosed. The go-to-market is referral-led, driven by cooperation with general practitioners, specialists, and tumor centers in Augsburg, Friedberg/Aichach, Donauwörth, München, and Ulm, with treatment plans coordinated through multidisciplinary tumor conferences. The practice holds DIN EN ISO 9001:2000, ESMO, certified endoscopy (Bayerische Landesärztekammer), and breast/gynecological cancer center certifications, and is the Hauptkooperationspartner at Darmzentrum Friedberg.

Name

Oncology Practice

Legal name

Onkologische Praxis Dr. med. Stephan Hochdörfer

Website

https://onkologiepraxis.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Onkologische Praxis Rehling is a private outpatient hematology-oncology practice in Rehling, Germany, founded in 2003, serving cancer, hematology, and palliative care patients across the Augsburg region through chemotherapy, immunotherapy, targeted therapy, and tumor conference-based treatment planning.

Ownership category

akta.pro rank

Product category

Outpatient Oncology and Hematology Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Breast Oncology (HLAKAFAJ), Gastrointestinal Oncology (HLAKAFAK)

Keywords

• Outpatient oncology care
• Hematology diagnostics
• Cancer chemotherapy services
• Palliative care treatment
• Immunotherapy administration

Headquarters

HQ city

Rehling

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Reimbursement (GKV/PKV): The practice generates revenue through reimbursement from the German statutory health insurance (GKV - Gesetzliche Krankenversicherung) and private health insurance (PKV - Private Krankenversicherung) for medical services including diagnostics, chemotherapy, immunotherapy, transfusions, and follow-up care.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

The Onkologische Praxis Rehling is an outpatient hematology-oncology practice with an attached day clinic (Tagesklinik) providing comprehensive diagnosis, therapy, and follow-up care for tumor diseases, blood disorders, and coagulation disorders. Core offerings include hematology-oncological diagnostics (ultrasound, punctures, endoscopies), outpatient chemotherapy, immunotherapy, targeted cancer therapy, transfusions, pain management, and palliative medicine. Treatment plans are coordinated through multidisciplinary regional tumor conferences in cooperation with local hospitals and tumor centers.

Product overview

Onkologische Praxis Rehling is a specialized hematology-oncology practice with a day clinic (Tagesklinik) offering comprehensive outpatient cancer care. The practice provides a unified service portfolio centered on diagnostics (tumor and blood disease diagnosis, imaging, punctures, endoscopies), followed by treatment modalities including chemotherapy, immunotherapy, targeted therapy, transfusions, pain management, and palliative care. All major therapeutic interventions are performed on an outpatient basis in their day clinic facility, with treatment plans coordinated through multidisciplinary tumor conferences. The practice serves patients in the Augsburg region through close collaboration with regional hospitals and tumor centers.

Differentiator

Problem solved

Functional benefit

Products and services

• Hämato-onkologische Diagnostik (Hemato-oncological Diagnostics) Comprehensive diagnostic services for solid tumors, blood diseases, and coagulation disorders including ultrasound examinations, various punctures (bone marrow, ascites, pleural, lymph node, lumbar), endoscopies, ECG monitoring, and cytological examinations, provided to patients referred by general practitioners and specialists in the Augsburg region.
• Chemotherapie (Ambulante Tagesklinik) — Outpatient Chemotherapy Outpatient chemotherapy treatment administered in the day clinic through infusions, tablets, or injections, with specially trained medical staff providing supervision and management of side effects.
• Immuntherapie (Immunotherapy) Cancer treatment that stimulates the body's own immune system to fight malignant tumors through targeted immune responses.
• Gezielte Krebstherapie (Targeted Cancer Therapy)
• Transfusionen (Transfusions)
• Schmerztherapie (Pain Management)
• Palliativmedizin (Palliative Medicine)
• Tumorkonferenzen-Teilnahme (Tumor Conference Participation)
• Supportive Therapie (Supportive Therapy)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core.

• Hausärzte (General Practitioners) in the regioncoreStrategic or Co-development PartnerClose cooperation with general practitioners in the region for patient referral and ongoing care coordination.
• Fachärzte (Specialists) in the regioncoreStrategic or Co-development PartnerCollaboration with specialist physicians in the region for comprehensive patient care.
• Tumorzentren in Augsburg, Friedberg/Aichach, Donauwörth, München, and UlmcoreStrategic or Co-development PartnerCooperation with specialized tumor centers in regional hospitals for multidisciplinary treatment planning and tumor conferences.
• Darmzentrum Friedberg (Colorectal Cancer Center Friedberg)coreStrategic or Co-development PartnerMain cooperation partner (Hauptkooperationspartner) in the colorectal cancer center in Friedberg near Augsburg for joint cancer treatment.
• Donau-Ries-Klinik Donauwörth (Breast and Gynecological Cancer Center)coreStrategic or Co-development PartnerCertification partnership in breast center and gynecological cancer center for coordinated cancer care delivery.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Asklepios Kliniken: Large private hospital group in Germany with hematology/oncology departments; comparable as a broad incumbent competing for outpatient oncology referrals and as a potential partner for practice acquisitions.
• Helios Kliniken: Germany's largest private hospital operator (part of Fresenius) offering oncology and hematology services across many sites; broader incumbent portfolio that competes with regional oncology practices for referrals and could be an acquirer/partner.
• Medicover: European healthcare provider operating outpatient clinics and diagnostic services including oncology in Germany; comparable as a multi-site outpatient operator that could roll up regional practices.
• Sana Kliniken: German private hospital chain with oncology service lines; competes broadly in regional markets and is a plausible aggregator of independent oncology practices.
• SRH Kliniken: German private hospital group providing oncology and hematology services across multiple sites; overlaps with the practice's category and represents potential competitive/partner dynamics.
• Schön Klinik: Private hospital group in Germany with specialty oncology and surgical oncology offerings; relevant as a broader incumbent in the same care category.

Regional players

• Darmzentrum Friedberg: Colorectal cancer center where the practice is the main cooperation partner; directly comparable as a regional oncology provider collaborating in multidisciplinary cancer care.
• Klinikum Augsburg: Major regional hospital offering multidisciplinary oncology care including chemotherapy, surgical oncology, and tumor board participation; competes with the practice for complex patient referrals in the Augsburg region.
• Universitätsklinikum Augsburg: Regional academic hospital providing inpatient and outpatient hematology/oncology services, including tumor boards and clinical trials, directly overlapping the practice's catchment area in Augsburg/Swabia.

Direct peers

• Donau-Ries-Klinik Donauwörth: Regional hospital partner of the practice with certified breast and gynecological cancer centers; directly comparable as a regional provider offering oncology services in the same catchment area.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/onkologische-praxis

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncology Practice